Abstract:In the process of drug development of RNA-targeting small molecules, elucidating the structural changes upon their interactions with target RNA sequences is desired. We herein provide a detailed in vitro and in-cell selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) protocol to study the RNA structural change in the presence of an experimental drug for spinal muscular atrophy (SMA), survival of motor neuron (SMN)-C2, and in exon 7 of the pre-mRNA of the SMN2 gene. In in vitro SHAPE, an RNA sequence of 140 nucleotides containing SMN2 exon 7 is transcribed by T7 RNA polymerase, folded in the presence of SMN-C2, and subsequently modified by a mild 2'-OH acylation reagent, 2-methylnicotinic acid imidazolide (NAI). This 2'-OH-NAI adduct is further probed by a 32P-labeled primer extension and resolved by polyacrylamide gel electrophoresis (PAGE). Conversely, 2'-OH acylation in in-cell SHAPE takes place in situ with SMN-C2 bound cellular RNA in living cells. The pre-mRNA sequence of exon 7 in the SMN2 gene, along with SHAPE-induced mutations in the primer extension, was then amplified by PCR and subject to next-generation sequencing. Comparing the two methodologies, in vitro SHAPE is a more cost-effective method and does not require computational power to visualize results. However, the in vitro SHAPE-derived RNA model sometimes deviates from the secondary structure in a cellular context, likely due to the loss of all interactions with RNA-binding proteins. In-cell SHAPE does not need a radioactive material workplace and yields a more accurate RNA secondary structure in the cellular context. Furthermore, in-cell SHAPE is usually applicable for a larger range of RNA sequences (~1,000 nucleotides) by utilizing next-generation sequencing, compared to in vitro SHAPE (~200 nucleotides) that usually relies on PAGE analysis. In case of exon 7 in SMN2 pre-mRNA, the in vitro and in-cell SHAPE derived RNA models are similar to each other.

Understanding the errors of SHAPE-directed RNA structure modeling

Correcting a SHAPE-directed RNA structure by a mutate-map-rescue approach

Modeling RNA secondary structure folding ensembles using SHAPE mapping data

Toward a Next-Generation Atlas of RNA Secondary Structure

Quantitative DMS mapping for automated RNA secondary structure inference

Characteristic chemical probing patterns of loop motifs improve prediction accuracy of RNA secondary structures.

SHAPE-Seq 2.0: systematic optimization and extension of high-throughput chemical probing of RNA secondary structure with next generation sequencing

Two-dimensional chemical mapping for non-coding RNAs

SHAPE Probing to Screen Computationally Designed RNA

Advances in RNA 3D Structure Modeling Using Experimental Data

Modeling Rna Topological Structures Using Small Angle X-Ray Scattering

STRUCT: a statistical approach to identify RNA secondary structures from raw sequencing data, bypassing multiple sequence alignment

Advances and Opportunities in RNA Structure Experimental Determination and Computational Modeling

Detecting Ribosnitches with RNA Folding Algorithms: a Genome-Wide Benchmark

Using structural and evolutionary information to detect and correct pyrosequencing errors in non-coding RNAs

Using In Vitro and In-cell SHAPE to Investigate Small Molecule Induced Pre-mRNA Structural Changes

Evaluating Performance of Different RNA Secondary Structure Prediction Programs Using Self-cleaving Ribozymes

Advances in the field of RNA 3D structure prediction and modeling, with purely theoretical approaches, and with the use of experimental data

Accurate RNA 3D Structure Prediction Using a Language Model-Based Deep Learning Approach

Exploring the accuracy of ab initio prediction methods for viral pseudoknotted RNA structures

RNA 3D structure prediction using multiple sequence alignment information